Nasdaq Hong Kong-Based Prenetics to go Public via SPAC The company recently launched a point-of-care and at-home rapid health monitoring system for infectious diseases. SeqLL to Go Public in $13M IPO The company, which was founded in 2013 to continue offering a sequencing technology developed by Helicos BioSciences, withdrew a planned IPO last year. Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO The firm offered 15,870,000 shares of its common stock, including 2,070,000 shares sold pursuant to the full exercise of the underwriters' option. Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring The notice was issued due to the company's extended period of non-compliance with the minimum $2.5 million stockholder's equity requirement for continued listing. Lucira Health Files for $115M IPO The company, which is developing instrument-free, low-cost molecular diagnostics platform for infectious disease testing, plans to float its shares on the Nasdaq. Jan 15, 2021 Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance Jan 7, 2021 Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent Oct 8, 2020 NanoString Technologies Prices $200M Public Offering Sep 11, 2020 10x Genomics Prices Upsized $440M Public Offering Sep 8, 2020 Biocept Completes Reverse Stock Split, Adds New Managed Care Contract for Liquid Biopsy Tests Aug 25, 2020 Berkeley Lights Q2 Revenues Fall 10 Percent Jul 17, 2020 Berkeley Lights Prices Upsized $178.2M IPO Jul 14, 2020 Piper Sandler Initiates Coverage of Progenity With Overweight Rating Jun 22, 2020 Burning Rock Raises $281.2M Through IPO, Private Placement Jun 19, 2020 Genetron Health Prices $256M US IPO Jun 17, 2020 T2 Biosystems Regains Compliance With Nasdaq Listing Requirements Jun 16, 2020 Progenity Eyes $122.6M in Amended IPO Jun 15, 2020 Genetron Health Targeting $175.5M in Amended US IPO May 11, 2020 10x Genomics Q1 Revenues Increase 34 Percent Apr 27, 2020 SeqLL Withdraws Plans for $8M IPO Apr 9, 2020 T2 Biosystems Receives Nasdaq Warning Letter Mar 16, 2020 Genetic Technologies Receives Nasdaq Delisting Notification Nov 7, 2019 Centogene Prices US IPO at $14 per Share Sep 13, 2019 10x Genomics CEO Says Firm 'Ready for Growth' Following $357.5M IPO Premium Aug 28, 2019 OpGen Plans Reverse Stock Split Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.